Clinical trialNCT06675994Not, yet, recruitingObservational

In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

SponsorLifeBridge HealthEnrollment80DiabetesFamily History of Cerebrovascular DiseaseFamily History of Coronary Artery DiseaseFamily History of Peripheral Artery DiseaseHealthyHypercholesterolemia+3 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Paul Gurbel, MD, FACC
LifeBridge Health
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Dec 2024
Primary completion: 1 Dec 2025
Completion: 30 Dec 2025
Last update posted: 6 Nov 2024
Registered enrollment: 80
Registry id: NCT06675994

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.